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Allelic exclusion underpins antigenic variation and immune evasion
in African trypanosomes. These bloodstream parasites use RNA
polymerase-I (pol-I) to transcribe just one telomeric variant surface
glycoprotein (VSG) gene at a time, producing superabundant and
switchable VSG coats. We identified trypanosome VSG exclusion-1
(VEX1) using a genetic screen for defects in telomere-exclusive ex-
pression. VEX1 was sequestered by the active VSG and silencing of
other VSGs failed when VEX1 was either ectopically expressed or
depleted, indicating positive and negative regulation, respectively.
Positive regulation affected VSGs and nontelomeric pol-I–transcribed
genes, whereas negative regulation primarily affected VSGs. Nega-
tive regulation by VEX1 also affected telomeric pol-I–transcribed re-
porter constructs, but only when they contained blocks of sequence
sharing homology with a pol-I–transcribed locus. We conclude that
restricted positive regulation due to VEX1 sequestration, combined
with VEX1-dependent, possibly homology-dependent silencing,
drives a “winner-takes-all” mechanism of allelic exclusion.
epigenetic | monoallelic | silencing | telomere | Trypanosoma brucei
Cells often restrict expression to a single allele of a gene orgene family. This allelic exclusion underpins antigenic variation
in pathogens, including trypanosomes that cause sleeping sickness
(1) and Plasmodium parasites that cause malaria (2). Allelic ex-
clusion is also essential for singular olfactory receptor expression
and a sense of smell in metazoa (3). Although many factors have
been identified that are required for the expression of one allele or
for the silencing of other alleles in these systems, our understanding
of the mechanisms by which expression and silencing are established
and coordinated remains incomplete (1–3).
The African trypanosome Trypanosoma brucei is a flagellated
parasitic protozoan transmitted among mammalian hosts by
tsetse flies. In addition to causing trypanosomiasis in humans, a
fatal and neglected tropical disease, these parasites also cause
nagana in cattle. Antigenic variation is essential for persistent
bloodstream infection in the face of host adaptive immune de-
fenses and has long been a paradigm for studies on allelic exclu-
sion (1); parasite immune evasion depends upon singular variant
surface glycoprotein (VSG) gene expression and VSG switching.
Although multiple subtelomeric VSGs are available for expression
(4), only one is transcribed (5). Both active and silent VSGs are
located at the ends of polycistronic transcription units known as
expression sites (ESs) (6). Notably, VSG-ES promoters (6) recruit
RNA polymerase-I (pol-I) that typically transcribes ribosomal
RNA genes (7). Indeed, the active VSG-ES is associated with an
extranucleolar focus of pol-I known as the expression-site body
(ESB) (8–10). Although the active VSG-ES is specifically depleted
of nucleosomes (11, 12), silent VSG-ESs are similarly located in
the extranucleolar space in bloodstream-form cells, and neither
active nor silent VSG-ESs show an appreciable association with
the nuclear envelope (13). An HMG chromatin protein that is
enriched and inversely correlated with nucleosome abundance at
the ESB and in the nucleolus (14) appears to maintain open
chromatin at these sites (15). In addition, a highly SUMOylated
focus is specific to the site of the ESB (16).
Pol-I transcription at the active VSG-ES, combined with atten-
uation at other VSG-ESs (17), allows trypanosomes to produce a
single superabundant VSG. Indeed, the active VSG generates the
most abundant T. brucei mRNA and protein. The mRNA exceeds
the next most abundant mRNA by >10-fold, and ∼10 million
VSGs, constituting 10% of total cell protein (18), form a dense
coat on each bloodstream-form cell (19). Antigenic variation itself
occurs at low frequency and without immune selection (20) due to
VSG rearrangement or coordinated transcription switching from
one VSG-ES to another, the latter occurring in the absence of
detectable change in the DNA sequence (1). Attempts to select for
two simultaneously transcribed VSG-ESs indicated that double
VSG expression is highly unstable (21).
Several reports link chromatin, chromatin-associated proteins,
and telomere-binding proteins to VSG silencing (SI Appendix,
Table S1). For example, a histone H3 variant, a bloodstream stage-
specific modified DNA base known as J or hydroxymethyluracil
(22, 23), the chromatin remodeling ISWI complex (24), the histone
H3K76 trimethyltransferase DOT1B (25), and the telomere-asso-
ciated protein RAP1 (26) all facilitate VSG-ES silencing. In addi-
tion, cohesin function facilitates maintenance of the active VSG-ES
(27), and inositol phosphate signaling impacts VSG-ES regulation
(28). Allelic exclusion, however, requires the establishment of dif-
ferential expression states and coordination among members of
a gene family, which are not understood (1–3). In the case of
T. brucei, it remains unclear how pol-I action is concentrated at
one telomeric VSG.
Significance
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trypanosomes to express just one VSG gene at a time.
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Results
A Genetic Screen Reveals Tb927.11.16920 as a Candidate VSG Exclusion
Regulator.To identify T. brucei genes that control telomere-exclusive
gene expression, we assembled an RNA interference (RNAi) li-
brary in bloodstream-form trypanosomes with a pol-I–transcribed
telomeric reporter. The Neomycin PhosphoTransferase (NPT) re-
porter, on a telomere-mediated chromosome-fragmentation con-
struct (29), incorporates an rDNA promoter and seeds a de novo
telomere, comprising TTAGGG repeats, ∼2 kbp downstream (Fig.
1A). The rDNA promoter can be switched on and off through allelic
exclusion when used to replace a native VSG-ES promoter (30) and
is subject to repression when located close to a telomere (31). A
reporter driven by an rDNA promoter was favored over a reporter
driven by a VSG-ES promoter because defects in allelic exclusion
were expected to result in a greater increase in NPT-reporter ex-
pression using the “stronger” rDNA promoter (32). Because VSG
expression is essential in bloodstream-form T. brucei (33), we also
reasoned that NPT activation, coupled to VSG silencing during a
“telomere-switch,” would fail to yield viable cells, as would knock-
downs previously linked to VSG silencing but associated with a
severe growth defect following RNAi (SI Appendix, Table S1).
The population that emerged from the screen for defects in telo-
mere-exclusive expression was subjected to RNAi target sequencing
(RIT-seq), revealing two genes, Tb927.6.4330 and Tb927.11.16920,
among ∼7,400 in the genome (Fig. 1B). To determine their impact
on VSG exclusion, we assembled pairs of independent RNAi
knockdown strains for each gene in cells with an active VSG-2 ES.
Upon Tb927.11.16920 knockdown, we observed a moderate growth
defect (SI Appendix, Fig. S1A) and derepression of the telomeric
NPT reporter used in the screen (Fig. 1C), thereby validating this
output from the screen. We confirmed efficient knockdown of myc-
epitope–tagged Tb927.11.16920 (Fig. 1D) and saw derepression of
silent telomeric VSGs using both protein blotting (Fig. 1D, VSG-6
panel) and microscopy (SI Appendix, Fig. S1B). These findings in-
dicate that the telomeric NPT reporter is subject to the exclusion
system operating in T. brucei. Analysis of Tb927.6.4430 supported
previous reports of disrupted VSG silencing when telomere structure
and/or function are compromised (26, 34); knockdown of this novel
telomeric TTAGGG repeat-associated factor (SI Appendix, Fig. S2
A and B) was associated with reporter and VSG derepression
(SI Appendix, Fig. S2 C and D), but these phenotypes were sub-
stantially weaker than those observed following Tb927.11.16920
knockdown (Fig. 1 C and D). Thus, Tb927.11.16920 emerged as the
primary “hit” in our screen for VSG exclusion regulators, and we
subsequently refer to this factor as VSG exclusion 1, or VEX1.
Like the majority of protein-coding genes identified in try-
panosome genomes, Tb927.11.16920/VEX1 encodes a “hypothet-
ical protein” with no prior functional assignment. Analysis of the
predicted peptide sequence revealed a 101.23-kDa protein in-
corporating a putative SWIM-type zinc finger with a CxCx17CxH
signature. Orthologous genes in other parasitic trypanosomatids
also encode the zinc-finger motif (SI Appendix, Fig. S3), originally
found in SWI2/SNF2 family ATPase, MuDR transposase, and
MEK kinase (35), but these hypothetical proteins also lack any
prior functional assignment.
VEX1 Is Sequestered at the Active VSG-ES.We next examined VEX1
subcellular localization. Epitope-tagged VEX1 was primarily con-
centrated in a single subnuclear focal compartment in blood-
stream-form cells, as revealed by superresolution microscopy (Fig.
2A and Movie S1). The VEX1 compartment was extranucleolar
(Fig. 2B) and closely associated, but not coincident, with the pol-I
focus (Fig. 2C and Movie S2) that is the site of the single active
VSG-ES (10). Because all competent VSG-ESs are telomeric, we
also used superresolution microscopy to assess VEX1 localization
relative to the telomeric TTAGGG repeat-binding factor TRF2
(34). This revealed punctate nuclear TRF2 staining and VEX1
staining that was coincident with a TRF2 punctum (Fig. 2D). VEX1
foci were observed at all cell-cycle phases, with segregated foci ac-
cumulating in G2 in particular, following DNA replication (Fig. 2E).
VEX1 foci were no longer detected, however, following a 30-min
exposure to the transcription inhibitor actinomycin D.
VSG expression is inactivated during differentiation to the
insect midgut stage and reactivated in the insect salivary gland
(36). We observed a widespread punctate nuclear distribution of
VEX1 in insect midgut-stage cells that substantially overlapped
with telomeric TRF2 puncta (Fig. 2F). Thus, VEX1 is seques-
tered at the active VSG-ES in a transcription-dependent and life
cycle stage-specific manner. VEX1 redistribution in insect-stage
cells may allow VSG-ESs to compete for VEX1 sequestration as
VSGs are reactivated in the insect salivary gland (37).
VEX1 Controls Telomeric VSG Exclusion. We next used microscopy
to examine VSG exclusion over a time course following VEX1
knockdown in bloodstream-form cells. This analysis revealed an
accumulation of cells simultaneously expressing VSG-2 and VSG-6
with no evidence for increased switching to VSG-6 (Fig. 3A). Flow
cytometry confirmed multi-VSG expression and, again, no evidence
for switching (Fig. 3B). To extend these findings, we carried out
transcriptome analysis using pairs of wild-type subclones and pairs
of independent knockdown strains, achieving >180× average ge-
nome coverage in each RNA-seq experiment. Assessment of VSG
transcript abundance in wild-type cells revealed a >1,000-fold dif-
ferential between the active VSG-2 transcript and the sum of all 18
“silent” pol-I promoter-associated VSGs; VSG-2 transcripts repre-
sented ∼7% of total mRNA. We also found that VEX1 produced a
low-abundance transcript in wild-type cells within the lowest fifth
Fig. 1. A genetic screen reveals a candidate VSG exclusion regulator. (A) The
bloodstream-form strain for RNAi screening was based on a repressed rDNA-
promoter/NPT-reporter cassette, with the promoter 2 kbp from the telomeric
TTAGGG repeats. Arrowheads, pol-I promoters; dashed line, transcription;
vertical bars, telomeres. (B) The schematic shows the RNAi screen for loss-of-
exclusion (in orange cells), and the genome map indicates hits following RIT-
seq (red spikes). Mapped reads are indicated relative to gene hits (dark bars).
(C) Tb927.11.16920 knockdown was associated with NPT derepression as
assessed by RNA blotting. TUB panel, loading control. (D) Knockdown of myc-
epitope–tagged Tb927.11.16920 was associated with VSG-6 derepression as
assessed by protein blotting. Coomassie-stained panel, loading control.
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percentile. Upon knockdown, VEX1 was depleted 3.1-fold on av-
erage (Fig. 3C and Dataset S1), whereas 19 genes (of ∼7,400)
displayed >3-fold and significantly (P < 0.05) increased expression
relative to wild type. These included many bloodstream ES-linked
VSGs, metacyclic ES-linked VSGs, and genes immediately adjacent
to VSGs (Fig. 3C and Dataset S1); metacyclic ES-linked VSGs are
transcribed by pol-I in the insect salivary gland (36). Indeed, ex-
pression of all 18 silent pol-I promoter-associated VSGs increased
>26-fold overall (Dataset S1).
We next released cell-surface VSGs and used quantitative pro-
teomics to examine relative expression (Fig. 3D and SI Appendix,
Materials and Methods and Table S2). VSG-2 on wild-type cells
displayed a relative abundance of 99.6%; only two significant se-
quences mapped to other VSGs. On VEX1-knockdown cells, the
VSG-2 relative abundance was 91% and 11 silent bloodstream and
metacyclic ES-linked VSGs were also detected (Fig. 3D and SI
Appendix, Table S2). Thus, VEX1 knockdown allows for silent
VSGs to be transcribed, translated, and delivered to the cell surface.
Overexpressed VEX1 Derepresses VSG-ESs and Nontelomeric pol-I
Loci. Although chromatin states may be effectively inherited,
establishment of “allele-choice” is not understood. The associ-
ation between VEX1 and the active VSG-ES, and maintenance
of the active VSG-ES following VEX1 knockdown, pointed to a
potential role for VEX1 in establishing the active VSG-ES. To
explore this hypothesis, we assembled a pair of independent
VEX1-overexpressing bloodstream-form strains. We observed a
moderate growth defect associated with VEX1 overexpression
(SI Appendix, Fig. S4 A and B), and, as predicted, these cells failed
to effectively sequester VEX1. Although a VEX1 focus was often
visible, we observed an additional dispersed signal through each
nuclear compartment (Fig. 3E). Consistent with our hypothesis,
when VEX1 was available to access a second telomeric VSG, this
VSG was derepressed (SI Appendix, Fig. S4B, VSG-6 panel). In-
deed, immunofluorescence microscopy (Fig. 3F) and flow cytometry
(Fig. 3G) revealed cells simultaneously expressing both VSGs. In
fact, the intensity of the cell-surface VSG-6 signal increased across
the entire population of each clone, and clones overexpressing
VEX1 lacking a myc tag yielded similarly increased VSG-6 ex-
pression (SI Appendix, Fig. S4C).
Transcriptome analysis revealed 65 genes that displayed more
than threefold and significantly (P < 0.05) increased expression in
VEX1 overexpresser strains relative to wild type. VEX1 mRNA was
increased 16-fold on average, and other up-regulated genes included
all 18 silent, pol-I promoter-associated VSGs, which increased >21-
fold overall (Fig. 3H and Dataset S1). A striking difference com-
pared with VEX1 knockdown was increased expression of 14 pro-
cyclin and procyclin-associated transcripts, also >21-fold overall (Fig.
3H, SI Appendix, Fig. S5A, and Dataset S1). These nontelomeric loci
are also transcribed by pol-I, but normally produce abundant surface
proteins in insect midgut-stage cells (7). Another difference was in-
creased expression of active (Dataset S1) and silent VSG-ES–asso-
ciated gene (ESAG) transcripts following VEX1 overexpression, in
contrast to increased expression of the VSGs only following VEX1
knockdown (SI Appendix, Fig. S5B). Quantitative proteomic analysis
of surface VSGs on VEX1-overexpressing cells revealed a VSG-2
abundance index reduced to 91%, with 12 additional bloodstream
and metacyclic ES-linked VSGs also detected (Fig. 3I and SI Ap-
pendix, Table S2). We conclude that overexpressed VEX1 positively
regulates both telomeric and nontelomeric pol-I–transcribed loci.
A VSG Reporter Is Subject to VEX1-Dependent Exclusion. VEX1 was
identified due to its ability to repress a reporter on a telomere-
mediated chromosome-fragmentation construct (Fig. 1). We rea-
soned that manipulation of these constructs would allow us to
identify the DNA sequences involved. A new construct was as-
sembled that contained a VSG-5 gene with a downstream se-
quence [including the 3′-untranslated region (3′-UTR)] that is
identical to that associated with the native active VSG-2 (Fig. 4A).
This construct places a VSG-5–associated rDNA promoter ∼7 kbp
Fig. 2. VEX1 associates with the active VSG-ES in bloodstream-form cells. (A) Three-dimensional structured-illumination immunofluorescence microscopy (3D
SIM) projection of VEX1myc. N, nucleus; K, kinetoplast (mitochondrial genome). (B) Immunofluorescence microscopy of VEX1myc and a nucleolar (No) marker
(NOG1). G1 (Left) and postmitotic (Right) cells are shown. (C) As in B but with a nucleolar plus ESB marker (pol-I). The linear intensity plot shows the distance
between the center of the VEX1 focus and the center of the ESB; mean distance is 0.34 ± 0.09 μm (n = 7 G1 nuclei). (Right) A 3D-SIM projection. (D) A 3D-SIM
projection of VEX1myc and GFPTRF2. (E) Immunofluorescence microscopy of VEX1myc during the cell cycle; phases are indicated and were inferred from DNA
content. Numbers of VEX1 foci per nucleus were quantified at each cell cycle phase and are plotted on the Right. (F) Immunofluorescence microscopy of
VEX1myc and GFPTRF2 in insect-stage cells. DNA was counterstained with DAPI. (Scale bars, 2 μm.)
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from a de novo telomere (Fig. 4A). Consistent with competition
between VEX1-mediated positive and negative regulation, we ob-
served variable outcomes using this construct in bloodstream-form
cells; all cloned populations continued to express VSG-2, but
VSG-5 expression differed. Among 24 independent clones, 20 dis-
played repressed VSG-5 and -4 are shown (Fig. 4B); 3 displayed
uniform repression (>99% of cells, clones 1–3) whereas some cells in
one clone displayed VSG-5 expression that interfered with native
VSG-2 expression (clone 4). The remaining clones displayed simul-
taneous expression of both VSGs (>99% of cells) that was stable
over many generations and yielded approximately equal quantities of
each VSG (Fig. 4B, clone 5, and SI Appendix, Fig. S6).
To determine whether VSG-5 repression was reversible, clone
3 cells were subcloned and selected for increased NPT-reporter
expression (Fig. 4A). These populations expressed VSG-5 that
interfered with VSG-2 expression (Fig. 4C), indicating that VSG-5
was subject to the exclusion system, being both repressible and
able to repress. Also, VEX1 knockdown led to VSG-5 derepression
and produced cells simultaneously expressing both VSGs (Fig. 4D).
This VEX1-dependent VSG-5 reporter repression was confirmed
using a second independent strain.
Fig. 3. VEX1 controls VSG allelic exclusion in bloodstream-form cells.
(A) Immunofluorescence microscopy analysis of VSG expression. Cells were
stained with α-VSG-2 and α-VSG-6 and counted daily during VEX1-RNAi. The
3D-SIM images show a wild-type control cell and a cell expressing both VSGs.
The images below the plot show cells following VEX1-RNAi (72 h). (Scale
bars, 5 μm.) (B) Flow-cytometry analysis of VSG expression following VEX1-
RNAi (72 h). Numbers indicate percentage of cells in each quadrant. VSG-6
expressers serve as a control. n = 10,000 cells in each case. (C) RNA-seq
analysis following VEX1-RNAi (72 h). Values are averages for a pair of in-
dependent strains (Dataset S1). Red circles, silent VSGs; red square, active
VSG; blue circles, procyclins and procyclin-associated genes. RPKM, reads per
kilobase of transcript per million mapped reads. (D) Quantitative mass
spectrometry analysis of surface VSGs following VEX1-RNAi (72 h) (SI Ap-
pendix, Table S2). (Inset) Wild-type cells for comparison. emPAI, exponen-
tially modified Protein Abundance Index. (E) Immunofluorescence microscopy
of overexpressed and ectopic VEX1myc (72 h). (Scale bar, 2 μm.) (Right) Se-
questered VEX1 for comparison. (F) Immunofluorescence microscopy analysis
of VSG expression following VEX1 overexpression (72 h). (Scale bar, 5 μm.) (G)
Flow cytometry following VEX1 overexpression (72 h). Other details are as in B.
(H) RNA-seq analysis following VEX1 overexpression (72 h). Other details are as
in C. (I) Quantitative mass spectrometry analysis of surface VSGs following
VEX1 overexpression (72 h) (SI Appendix, Table S2).
Fig. 4. VEX1-dependent communication among recombinant and native VSGs.
(A) The schematic shows the VSG-5 reporter in cells expressing native VSG-2.
Blue boxes, common VSG 3′-UTRs; pA, poly-adenylation sites; other symbols as in
Fig. 1A. (B) The protein blots show five bloodstream-form clones derived using
this system. VSG-5– or VSG-2–expressing wild-type (WT) cells serve as controls.
The Coomassie-stained panel serves as a loading control and also reveals the
major VSGs. The immunofluorescence panels show VSG expression in clones 3–5.
(C) Immunofluorescence analysis of VSG expression in a subclone of clone 3
following G418/NPT-selection (see A). (D) The protein blots and immunofluo-
rescence microscopy show VSG-5 expression during VEX1 knockdown. (E) Im-
munofluorescence microscopy analysis of VEX1myc in clone 5 cells (expressing
both VSG-2 and VSG-5). Nuclei with one or two VEX1 foci were quantified
relative to wild type and cells equivalent to clone 3 above (expressing VSG-2
only). Immunofluorescence analysis of VEX1myc and pol-I reveals the location
of the additional VEX1 focus relative to the ESB and nucleolus (No). The mean
distance between the centers of the VEX1 foci is 1.1 ± 0.3 μm (n = 8 G1 nuclei).
(Scale bars in B, C, and D, 5 μm; in E, 1 μm.) DNAwas counterstained with DAPI.
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Simultaneous expression of two VSGs in clone 5 (Fig. 4B)
indicated that VSG-5 could escape exclusion in the presence of
VEX1. Indeed, simultaneous VSG expression, apparently at
distinct telomeres, has been reported before (38). Because
VEX1 is concentrated at the active VSG-ES (Fig. 2) and can
positively regulate pol-I loci (Fig. 3 E–I), we wondered whether
VSG-5 at a de novo telomere might compete for VEX1 and, in
some cases, acquire sufficient material to establish a second
“privileged” site. As suspected, the proportion of nuclei with
two distinct VEX1 foci was increased in clone 5 cells (3.8-fold
relative to “wild-type” control; Fig. 4E), and the additional
VEX1 focus associated with VSG-5 expression was typically
ESB-distal and perinucleolar (Fig. 4E); rDNA loci are also
perinucleolar (39). Taken together with analysis of VEX1 over-
expressers (Fig. 3H), these findings (Fig. 4 B and E) suggest that
access to VEX1 increases pol-I transcription, that increased pol-I
transcription can lead to the accumulation of VEX1, or both
of the above. This is also consistent with the observation of a
“preactive” VSG state when a VSG is in close proximity to the
active VSG-ES (21).
VEX1 Mediates a Form of Homology-Dependent Silencing. A seren-
dipitous observation initially suggested to us that “homologous”
DNA sequences might be important for exclusion. We had as-
sembled a bicistronic and telomeric GFP:NPT reporter that
fortuitously contained identical sequences downstream of both
the GFP and NPT genes (Fig. 5A, Upper map). These sequences
contain 3′-UTRs that are included in reporter constructs to
guide mRNA polyadenylation and splicing; we did not expect
them to be subject to repression or exclusion. However, we ob-
served strong NPT repression when using this construct in
bloodstream-form cells (Fig. 5A, Left, common UTR lanes). To
determine whether this reflected homology-dependent in-
terference, the T. brucei aldolase sequence downstream of the
GFP gene was replaced with a T. brucei tubulin sequence (Fig.
5A, Lower map), which is unrelated to the aldolase sequence but
also guides efficient mRNA processing. No NPT repression
was observed when using this construct (Fig. 5A, Right, distinct
UTR lanes). In cells containing the construct with common al-
dolase sequences, NPT repression was relieved following VEX1
knockdown (Fig. 5B); a result confirmed using a second in-
dependent strain. Thus, reporters with homologous sequences
downstream displayed VEX1-dependent repression that no
longer operated when homology was removed.
Discussion
We identified trypanosome VEX1 using a genetic screen
for defects in telomere-exclusive gene expression. VEX1 is
sequestered at the active VSG-ES and coordinates VSG-positive
and -negative regulation to sustain antigenic variation. Based on
our findings, we propose a winner-takes-all model for the es-
tablishment of allelic exclusion by VEX1 (Fig. 6A). A similar
model has been put forward for olfactory receptor gene choice
(40) although no factor that displays similar properties to VEX1
has been identified in that system. Our results indicate that an
established active VSG-ES is effectively inherited when VEX1
function is disrupted; this also appears to be the case when
(telomeric) chromatin is disrupted by other means (22–24, 26, 34).
One long-standing question, however, has been why are silent
VSG-ESs only partially derepressed when (telomeric) chromatin is
disrupted? This is the case even when substantial loss of viability is
observed, following RAP1 knockdown, for example (26), and
could be explained by failure to associate with sufficient tran-
scription or RNA-processing factors. We suggest that, when
VEX1 function is disrupted, directly or indirectly, negative regu-
lation is relaxed but silent VSG-ESs lack VEX1-mediated positive
regulation (Fig. 6B). Indeed, VSG-ES promoters appear to be
substantially “weaker” than rDNA promoters (32) and may de-
pend upon positive regulation by VEX1. In the case of excess
VEX1, access to other VSG-ESs allows positive regulation, but
these sites are still subject to negative regulation exerted by the
active VSG-ES (Fig. 6C). Thus, we suggest that the “default” level
for VSG expression is relatively low and that VEX1 drives the
processes that increase expression at one locus and reduce ex-
pression elsewhere. We note that although a winner-takes-all
mechanism may operate naturally, this can be perturbed either
when VEX1 is artificially expressed in excess or, in some cases,
when recombinant pol-I transcription units are introduced
de novo.
We previously demonstrated that repression of pol-I–transcribed
genes spreads only a short distance from the telomere in the ab-
sence of additional VSG-ES sequences (31). We now show that this
repression is VEX1-dependent and also that homologous se-
quences can promote VEX1-dependent repression. Another recent
report demonstrated that a VSG, transcribed at a chromosome-
internal site by T7-phage polymerase, transiently silenced the native
VSG (25). This same report demonstrated repression spreading along
the VSG-ES in a DOT1B, histone methyltransferase-dependent
Fig. 5. VEX1-dependent communication among homologous sequences.
(A) The schematic shows reporters with common or distinct 3′-UTRs (blue,
aldolase; orange, tubulin). The protein blots show reporter expression for
pairs of bloodstream-form clones derived using each construct. Coomassie-
stained panel, loading-control. Symbols as in Fig. 4A. (B) The immunofluo-
rescence panels and protein blots show expression of reporters with common
3′-UTRs during VEX1 knockdown. (Scale bar, 5 μm.)
Fig. 6. A winner-takes-all model for allelic exclusion by VEX1. (A) Wild-type
bloodstream-form cells: VEX1 coordinates VSG-positive and -negative regulation.
VEX1 (green) is recruited to a single VSG-ES through positive feedback involving
pol-I transcription. VEX1 also exerts negative regulation through homology-
dependent silencing (red symbol), which enhances differential expression and
ensures that the winner takes all. (B) VEX1 knockdown: Insufficient VEX1 leads to
relaxed homology-dependent silencing but also precludes further positive reg-
ulation. An established active VSG-ES is maintained in the absence of VEX1. (C)
VEX1 overexpression: Ectopic VEX1 positively regulates all VSG-ESs, but negative
regulation also persists and precludes further derepression.
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manner (25). Spreading of a repressed domain may also explain why
we see derepression of both bicistronic GFP and NPT reporters
during VEX1 knockdown (Fig. 5B). In these experiments, sequences
that are subject to repression also serve as repressive sequences when
they are transcribed. VSG transcripts (SI Appendix, Fig. S7) and other
VSG-associated sequences display a high degree of homology, and
telomeric TTAGGG-repeat transcripts are also present in T. brucei
(41), suggesting that transcripts could be involved. Further work will
be required to delineate the mechanism, which, although not in-
volving Argonaute1-based RNAi (42), could involve alternative
RNA-based repression, as reported in other cell types (43). Thus, we
tentatively suggest that VEX1-dependent VSG silencing is initiated
by homologous transcripts and is then propagated along the chro-
matin fiber in a DOT1B-dependent manner.
In summary, we report the identification of VEX1, an allelic
exclusion regulator that sustains antigenic variation in trypano-
somes. We describe a winner-takes-all model whereby VEX1
sequestration establishes a single active VSG-ES that then me-
diates homology-dependent silencing at other VSG-ESs. Similar
mechanisms involving positive and negative regulation, coordi-
nated by sequestered regulators, could explain allelic exclusion in
other cell types.
Materials and Methods
For details of T. brucei growth and manipulation, plasmids, nucleic acid analysis,
Western blotting, microscopy, flow cytometry, and quantitative mass spec-
trometry, see SI Appendix, Materials and Methods.
T. brucei, Lister 427, MITat1.2 (VSG-2, aka VSG221), 1.5 (VSG-5, aka VSG118),
and 1.6 (VSG-6, aka VSG121) cells were used for this study. RIT-seq was carried out
on a MiSeq platform (Illumina) at The Beijing Genome Institute (BGI). RNA-seq
was carried out on a HiSeq platform (Illumina) at the University of Dundee or at
BGI. Three-dimensional structured illumination microscopy was carried out using a
superresolution OMX Blaze system (GE Healthcare). Quantitative mass spectrom-
etry was carried out using an Ultimate 3000 RSLCnano system (Thermo Scientific)
coupled to a Linear Trap Quadropole OrbiTrap Velos Pro (Thermo Scientific).
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